AGP Executive Report
Last update: an hour agoEbola Crisis Escalates: In DR Congo’s Ituri, attackers burned down a tent used to treat Ebola victims in Mongbwalu, sending at least 18 suspected patients fleeing and triggering panic at the hospital—while WHO says the outbreak risk is now “very high” and Uganda reported three more cases, bringing its total to five. Public Health Under Pressure: The WHO update also notes the outbreak’s spread may have been underway for months, with suspected cases and deaths climbing fast. Neurology Breakthrough: A new study using real-time imaging overturns the idea that astrocytes keep uniform sodium levels, showing sodium micro-domains fluctuate to match local brain excitability needs. Regulatory/Drug Watch: The FDA accepted Bayer’s asundexian NDA for priority review in secondary stroke prevention, and the EU approved Pharming’s Joenja for APDS. Germany in Focus: A new AI “MouseMapper” platform links obesity to widespread inflammation and previously unknown nerve damage, with similar patterns found in human tissue.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/b82cb0dd-e6c7-45cb-9174-713d3784302f/north-america-genome-editing-market-size-2025-to-2035-usd-billion-.png)
